• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Surgery for Breast Cancer Prevention.

作者信息

Jatoi Ismail, Kemp Zoe

机构信息

University of Texas Health Science Center, San Antonio.

Royal Marsden Hospital, NHS Trust, London, England.

出版信息

JAMA. 2021 May 4;325(17):1804. doi: 10.1001/jama.2021.1647.

DOI:10.1001/jama.2021.1647
PMID:33944874
Abstract
摘要

相似文献

1
Surgery for Breast Cancer Prevention.预防乳腺癌的手术
JAMA. 2021 May 4;325(17):1804. doi: 10.1001/jama.2021.1647.
2
Risk-Reducing Mastectomy.降低风险的乳房切除术。
JAMA. 2021 May 4;325(17):1781-1782. doi: 10.1001/jama.2020.22414.
3
Bilateral risk-reducing mastectomy in BRCA mutation carriers: A difficult decision-making.BRCA 突变携带者的双侧预防性乳房切除术：艰难的决策。
Breast J. 2019 May;25(3):564-565. doi: 10.1111/tbj.13287. Epub 2019 Apr 9.
4
Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?卵巢癌治疗后BRCA突变携带者的预防性乳房切除术：有益吗？
Expert Rev Anticancer Ther. 2018 Mar;18(3):199-200. doi: 10.1080/14737140.2018.1424547. Epub 2018 Jan 8.
5
Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.保乳术后即刻乳房重建的适应证变化和长期肿瘤学结果。
BJS Open. 2018 Nov 26;3(2):169-173. doi: 10.1002/bjs5.50117. eCollection 2019 Apr.
6
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术：外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
7
Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers.预防性乳房切除术与监测对携带BRCA基因女性预防乳腺癌的作用比较
Medwave. 2018 Jul 9;18(4):e7161. doi: 10.5867/medwave.2018.04.7160.
8
Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.BRCA1/2 种系突变携带者单侧和双侧预防性乳房切除术的残留腺体组织 (RGT)。
Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.
9
Contralateral Prophylactic Mastectomy.对侧预防性乳房切除术
N Engl J Med. 2017 Sep 28;377(13):1288-1291. doi: 10.1056/NEJMclde1708293.
10
Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop Bra mesh in BRCA1/2 mutation carriers: A prospective study of long-term and patient reported outcomes using the BREAST-Q.BRCA1/2 突变携带者中使用 TiLoop Bra 网片行保留乳头的双侧预防性乳房切除术和即刻重建：使用 BREAST-Q 评估长期和患者报告结局的前瞻性研究。
Breast. 2018 Jun;39:8-13. doi: 10.1016/j.breast.2018.02.001. Epub 2018 Feb 18.

引用本文的文献

1
TP53AIP1 induce autophagy via the AKT/mTOR signaling pathway in the breast cancer cells.TP53AIP1 通过 AKT/mTOR 信号通路诱导乳腺癌细胞自噬。
Cancer Biol Ther. 2024 Dec 31;25(1):2398297. doi: 10.1080/15384047.2024.2398297. Epub 2024 Sep 2.
2
Perioperative Administration of Pregabalin and Esketamine to Prevent Chronic Pain After Breast Cancer Surgery: A Randomized Controlled Trial.普瑞巴林和 Esketamine 用于预防乳腺癌手术后慢性疼痛的围手术期管理：一项随机对照试验。
Drug Des Devel Ther. 2023 Jun 8;17:1699-1706. doi: 10.2147/DDDT.S413273. eCollection 2023.
3
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
EBCC-13 宣言：权衡利弊，决定是否行对侧预防性乳房切除术。
Eur J Cancer. 2023 Mar;181:79-91. doi: 10.1016/j.ejca.2022.11.036. Epub 2022 Dec 13.
4
RBM8A Depletion Decreases the Cisplatin Resistance and Represses the Proliferation and Metastasis of Breast Cancer Cells via AKT/mTOR Pathway.RBM8A 耗竭通过 AKT/mTOR 通路降低顺铂耐药性并抑制乳腺癌细胞的增殖和转移。
Breast J. 2022 Aug 28;2022:4576789. doi: 10.1155/2022/4576789. eCollection 2022.
5
Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells.左旋千金藤啶碱通过激活乳腺癌细胞中的 Nrf2/HO-1 信号通路诱导铁死亡。
Drug Des Devel Ther. 2022 Sep 7;16:2981-2993. doi: 10.2147/DDDT.S374328. eCollection 2022.
6
Identification of pyroptosis related subtypes and tumor microenvironment infiltration characteristics in breast cancer.鉴定乳腺癌中的细胞焦亡相关亚型和肿瘤微环境浸润特征。
Sci Rep. 2022 Jun 23;12(1):10640. doi: 10.1038/s41598-022-14897-1.
7
Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.长链非编码 RNA CDKN2B-AS1 的敲低通过 miR-122-5p/STK39 轴抑制乳腺癌的进展。
Bioengineered. 2021 Dec;12(1):5125-5137. doi: 10.1080/21655979.2021.1962685.